ID
17654
Beskrivning
Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc (OSI Pharmaceuticals) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part of study: Open-label Tarceva Consent and Eligibility
Länk
https://clinicaltrials.gov/ct2/show/NCT00373425
Nyckelord
Versioner (2)
- 2016-08-02 2016-08-02 -
- 2016-09-27 2016-09-27 -
Uppladdad den
27 september 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Open-label Tarceva, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425
Open-label Tarceva Consent and Eligibility, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425
Beskrivning
Open-label Tarceva Eligibility
Beskrivning
Open-label Tarceva Eligibility
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1516637
Beskrivning
Eligibility Criteria: OSI-774-302 Protocol Version 2, 21 November 2007, Appendix 12.9
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1302261
Beskrivning
Eligibility Criteria
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1516637
Beskrivning
Eligibility Criteria
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1516637
Beskrivning
Eligibility Criteria
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1516637
Beskrivning
Eligibility Criteria
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1516637
Beskrivning
Exemption
Datatyp
integer
Alias
- UMLS CUI [1,1]
- C1516637
- UMLS CUI [1,2]
- C2348482
Beskrivning
Investigator Signature
Beskrivning
I have reviewed all data for this patient's eligibility and confirm that consent has been obtained in accordance with the GCP Directive (2005/28/EC) or EU Directive (2001/20/EC) and other applicable GCP requirements.
Datatyp
text
Alias
- UMLS CUI [1]
- C2346576
Beskrivning
Investigator Signature Date
Datatyp
date
Alias
- UMLS CUI [1,1]
- C2346576
- UMLS CUI [1,2]
- C0011008
Similar models
Open-label Tarceva Consent and Eligibility, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425
C1135136 (UMLS CUI [1,2])
C2348482 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])